Claus Møller, CEO of Danish-American cancer company, Y-mabs, has big dreams for the future. According him, the company could develop "the Tesla within biotechnology," he says in an interview with Danish business daily Børsen.
"This could be a game changer for how to treat cancer just like how Tesla changed the car industry when it comes to the transition from fossil fuel cars to electric vehicles," Møller says.
Already a subscriber? Log in.
Read the whole article
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.Start a free company trial today
Your trial for MedWatch has now started
With your free trial you get:
Full access to all locked articles on MedWatch.
Daily newsletter and ongoing top-newsletters. You can unsubscribe and subscribe to our newsletters anytime.
When your trial period expires
You will not be transferred to a paid subscription.
You will continue to receive our newsletters after the trial period expires. You can unsubscribe at the bottom of each newsletter.